Knome taps Pfizer vet as new CEO

With plans to up its game in the biopharma and healthcare arenas, genome interpretation provider Knome has hired veteran biotech executive Martin Tolar as its new chief executive, the company announced today. Prior CEO Jorge Conde has been named chief strategy officer and reports to the new chief executive, Tolar said in an interview with FierceBiotech IT. Story